(:NVTR)

Nov 12, 2019 05:35 pm ET
Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11
Nuvectra Corporation (NASDAQ: NVTR) (“Nuvectra” or the “Company”), a neurostimulation medical device company, today announced that it has elected to file a voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code...
Oct 18, 2019 08:00 am ET
Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis™ 
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition and biocompatibility data to the U.S. Food and Drug Administration (FDA) in support of the Company’s...
Sep 20, 2019 08:30 am ET
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective September 16, 2019. Ms. Kosharek will assume the role of Chief Financial...
Aug 26, 2019 04:05 pm ET
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore potential strategic alternatives to enhance shareholder value. The Company is currently evaluating...
Jul 31, 2019 04:01 pm ET
Nuvectra® Reports Second Quarter 2019 Financial Results
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2019. Recent Business Highlights Algovita® revenues increased 7% year-over-year to $12.3...
Jul 17, 2019 08:30 am ET
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 after market close. Nuvectra will...
Jun 12, 2019 04:05 pm ET
Nuvectra® to Participate in Two Upcoming Investor Conferences
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming investor conferences in New York, NY.               Event:    Raymond James...
Jun 11, 2019 04:05 pm ET
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug Administration (FDA) for full-body MR-conditional approval for the Company’s...
May 30, 2019 08:30 am ET
Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary Algovita® clinical data from its U.S. and EU multi-center, single-arm study demonstrating lead fracture and migration rates that were below...
May 16, 2019 09:00 am ET
Nuvectra® Announces Departure of COO & CFO Walter Z. Berger
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that Walter Z. Berger has resigned as Nuvectra’s Chief Operating Officer and Chief Financial Officer to pursue another business opportunity, effective...
May 01, 2019 04:01 pm ET
Nuvectra® Reports First Quarter 2019 Financial Results
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2019. Recent Business Highlights Increased Algovita® revenues 22% YoY to $11.0...
Apr 22, 2019 04:05 pm ET
Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended March 31, 2019 on Wednesday, May 1, 2019 after market close. Nuvectra will hold...
Apr 17, 2019 07:00 am ET
Recent Analysis Shows Nuvectra, Red Lion Hotels, Rave Restaurant Group, Aeglea BioTherapeutics, CPI Aerostructures, and Qumu Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nuvectra Corporation (NASDAQ:NVTR), Red Lion Hotels Corporation...
Mar 25, 2019 08:01 am ET
Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Anthony P. Bihl, III as Chairman of the Board of Directors, following Dr. Joseph A. Miller’s retirement from the Board, effective...
Feb 28, 2019 04:01 pm ET
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the fourth quarter and full year ended December 31, 2018. Recent Highlights Record consolidated revenues of $14.5 million and...
Feb 26, 2019 08:30 am ET
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the...
Feb 21, 2019 08:00 am ET
The Future Is Now; Med Tech That’s Changing Lives
Investorideas.com, a leading investor news resource covering medical technology and healthcare stocks releases a snapshot looking at the rapid advancements happening in the med tech sector and how many of these “far off” projects are now on the...
Feb 19, 2019 08:30 am ET
Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2018 on Thursday, February 28, 2019 after market...
Jan 31, 2019 05:01 pm ET
Nuvectra® Appoints Dr. Fred B. Parks as Chief Executive Officer
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Fred B. Parks, PhD, as Chief Executive Officer, effective immediately. Dr. Parks has served as a member of the Company’s Board of...
Jan 29, 2019 04:01 pm ET
Nuvectra Provides Update on Virtis™ FDA PMA Submission
Nuvectra Corporation (NASDAQ: NVTR), a medical device company dedicated to neuromodulation, announced today that the U.S. Food and Drug Administration (FDA) has advised that its review of Company’s pre-market approval (PMA) application for its...
Jan 07, 2019 05:30 am ET
Nuvectra® Announces Preliminary Unaudited Fourth Quarter and Full Year 2018 Revenue
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2018. Preliminary unaudited consolidated revenue in the fourth...
Jan 02, 2019 08:30 am ET
Nuvectra Announces Divesture of NeuroNexus Subsidiary
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has entered into an agreement effective December 31, 2018, to sell its wholly owned subsidiary NeuroNexus Technologies, Inc. (“NeuroNexus”) to...
Dec 12, 2018 08:01 am ET
Nuvectra Receives Full-Body MR-Conditional CE Mark Approval for Algovita®
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received full-body MR-conditional approval for the Company’s Algovita SCS system from its European Notified Body, TÜV SÜD. The approval...
Dec 06, 2018 08:01 am ET
Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation (SCS) system has been implanted in over 3,000 patients in the U.S. The Algovita system utilizes...
Dec 03, 2018 08:01 am ET
Nuvectra Receives FDA Head-Only MR-Conditional Approval for Algovita®
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) head-only MR-conditional approval for the Company’s Algovita SCS system. Scott...
Nov 13, 2018 07:45 am ET
New Research Coverage Highlights National American University, Moog, TCP Capital, TriplePoint Venture Growth BDC, Occidental Petroleum, and Nuvectra — Consolidated Revenues, Company Growth, and Expect
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of National American University Holdings, Inc. (NASDAQ:NAUH), Moog Inc....
Oct 31, 2018 08:01 am ET
Nuvectra® to Participate in Two Upcoming Investor Conferences
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate in two...
Oct 29, 2018 04:01 pm ET
Nuvectra® Reports Third Quarter 2018 Financial Results
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the third quarter ended September 30, 2018. Highlights Record consolidated revenues of $14.2 million, up 87% YoYConsolidated...
Oct 22, 2018 08:01 am ET
Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the third quarter ended September 30, 2018 on Monday, October 29, 2018 after market close. Nuvectra...
Sep 14, 2018 12:00 pm ET
Nuvectra® Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public offering of 3,248,750 shares of its common stock at a price to the public of $21.25 per share, which...
Sep 11, 2018 10:09 pm ET
Nuvectra® Announces Pricing of Follow-On Stock Offering
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the public of $21.25 per share. The...
Sep 11, 2018 04:01 pm ET
Nuvectra® Announces Proposed Follow-On Stock Offering
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on public offering of its common stock. In addition, Nuvectra intends to grant the underwriters a 30-day...
Sep 05, 2018 04:01 pm ET
Nuvectra to Participate in Two Upcoming Investor Conferences
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer Chief Financial Officer, are scheduled to participate in two...
Aug 07, 2018 04:01 pm ET
Nuvectra™ Reports Second Quarter 2018 Financial Results
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2018. Highlights Reported record consolidated revenues of $13.1 million for the second quarter...
Aug 02, 2018 04:01 pm ET
Nuvectra™ Appoints Neuromodulation Veteran Ben Tranchina as Chief Technology Officer
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the appointment of Ben Tranchina as Chief Technology Officer (CTO), effective August 24, 2018. Mr. Tranchina has over 25 years of industry experience...
Jul 31, 2018 04:01 pm ET
Nuvectra™ to Report Second Quarter 2018 Financial Results on August 7, 2018
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2018 on Tuesday, August 7, 2018 after market close. Nuvectra will hold...
Jul 10, 2018 08:01 am ET
Nuvectra Completes 2,000 U.S. Algovita® SCS System Implantations
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation (SCS) system has been implanted in over 2,000 patients in the U.S. The Algovita SCS System utilizes...
Jul 02, 2018 07:30 am ET
Nuvectra Provides Update on FDA and TÜV SÜD Review of Virtis™ PMA and CE Mark Applications
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today provided an update on its U.S. Food and Drug Administration (FDA) pre-market approval (PMA) application and its TÜV SÜD application for CE Mark in Europe for...
Jun 25, 2018 08:01 am ET
Nuvectra Added to the Russell 2000® Index
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it was added to the Russell 2000® Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 22,...
May 17, 2018 08:30 am ET
Nuvectra to Present at Two Upcoming Investor Conferences
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer Chief Financial Officer, are scheduled to present at two upcoming...
May 02, 2018 04:01 pm ET
Nuvectra™ Reports First Quarter 2018 Financial Results
PLANO, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2018.
Apr 23, 2018 04:01 pm ET
Nuvectra™ to Report First Quarter 2018 Financial Results on May 2, 2018
PLANO, Texas, April 23, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended March 31, 2018 on Wednesday, May 2, 2018...
Mar 06, 2018 04:01 pm ET
Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results
Record Quarterly Algovita® Revenue of $10.4 Million
Feb 27, 2018 08:30 am ET
Nuvectra to Present at Two Upcoming Investor Conferences
PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present...
Feb 22, 2018 04:01 pm ET
Nuvectra™ to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018
PLANO, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2017 on Tuesday,...
Feb 20, 2018 08:30 am ET
Nuvectra Secures $45 Million Second Amendment to Existing Loan and Security Agreement
Agreement Provides Company with Increased Financial Flexibility and Extended Amortization Period
Feb 05, 2018 04:01 pm ET
Nuvectra™ Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
PLANO, Texas, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public offering of 3,248,750 shares of its common stock at a price to the...
Feb 01, 2018 09:00 am ET
Nuvectra™ Announces Pricing of Follow-On Stock Offering
PLANO, Texas, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the...
Jan 31, 2018 04:01 pm ET
Nuvectra™ Announces Proposed Follow-On Stock Offering
PLANO, Texas, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on public offering of its common stock. In addition, Nuvectra intends to grant the...
Jan 08, 2018 08:00 am ET
Nuvectra™ Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue
PLANO, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2017.
Jan 03, 2018 04:01 pm ET
Nuvectra Announces Analyst & Investor Meeting at NANS 2018
Event to Feature Leading Physician Presentations on Nuvectra’s Algovita system
Dec 13, 2017 08:01 am ET
Nuvectra Achieves 1,000th Algovita® SCS System Implantation in U.S.
PLANO, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the company’s Algovita® Spinal Cord Stimulation (SCS) system has now been implanted in 1,000 patients across the U.S. seeking...
Nov 15, 2017 04:01 pm ET
Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference
PLANO, Texas, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present...
Nov 06, 2017 04:01 pm ET
Nuvectra to Present at the Stifel 2017 Healthcare Conference
PLANO, Texas, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate...
Nov 06, 2017 04:01 pm ET
Nuvectra to Present at the Stifel 2017 Healthcare Conference
PLANO, Texas, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate at the Stifel 2017 Healthcare Conference in New York, NY....
Nov 01, 2017 04:01 pm ET
Nuvectra™ Reports Third Quarter 2017 Financial Results
Record Quarterly Algovita Revenues, Increasing to $6.3 Million
Nov 01, 2017 04:01 pm ET
Nuvectra™ Reports Third Quarter 2017 Financial Results
PLANO, Texas, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the third quarter ended September 30, 2017....
Oct 24, 2017 08:01 am ET
Nuvectra to Report Third Quarter 2017 Financial Results on November 1, 2017
PLANO, Texas, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the third quarter ended September 30, 2017 on Wednesday, November 1, 2017 after market close....
Sep 11, 2017 08:00 am ET
First Spinal Cord Stimulator Implant Placed in Northern California by Dr. Goldthwaite Brings Pain Relief and Reduces Opioid Use for Local Injured Veteran
PLANO, Texas, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Noel Goldthwaite, MD, senior surgeon and founding member at SpineCare Medical Group, Inc., is the first physician in northern California to implant Nuvectra’s Algovita® Spinal Cord Stimulation System, which successfully treated a local injured veteran’s chronic pain and led to his significant reduction in opioid use. The Nuvectra Algovita SCS System is a powerful and versatile spinal cord stimulation system that includes the smallest patient controller on the market. Algovita is FDA approved as a treatment for chronic, intractable pain....
Aug 30, 2017 04:01 pm ET
Nuvectra to Participate in Morgan Stanley Global Healthcare Conference
PLANO, Texas, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & CFO, are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York, NY....
Jul 25, 2017 04:01 pm ET
Nuvectra to Report Second Quarter 2017 Financial Results on August 8, 2017
PLANO, Texas, July 25, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2017 on Tuesday, August 8, 2017 after market close....
May 09, 2017 04:01 pm ET
Nuvectra™ Reports First Quarter 2017 Financial Results
PLANO, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2017....
May 03, 2017 08:01 am ET
Nuvectra to Present at the 18th Annual B. Riley Co. Investor Conference
PLANO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the 18th Annual B. Riley Co. Investor Conference in Santa Monica, CA. Management will also be available for one-on-one meetings at the conference....
Apr 27, 2017 08:30 am ET
Nuvectra to Report First Quarter 2017 Financial Results on May 9, 2017
PLANO, Texas, April 27, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended March 31, 2017 on Tuesday, May 9, 2017 after market close....
Mar 27, 2017 08:30 am ET
Nuvectra Announces Cowen & Company Hosted Physician Panel on Spinal Cord Stimulation on March 29, 2017
PLANO, Texas, March 27, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Cowen and Company and The Ruth Group are hosting a physician panel on the spinal cord stimulation market and the Algovita system. The event will feature discussions with Jeffery Rowe, MD, and Brian Bannister, MD, and will be moderated by Cowen medical technology analyst Josh Jennings, MD....
Mar 06, 2017 08:01 am ET
Nuvectra to Present at the 29th Annual ROTH Conference
PLANO, Texas, March 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the 29th Annual ROTH Conference in Dana Point, CA. Management will also be available for one-on-one meetings at the conference....
Feb 14, 2017 04:01 pm ET
Nuvectra Extends Timeline of Existing Credit Facility
PLANO, Texas, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has reached an agreement with the lenders of its $45 million credit facility, Silicon Valley Bank and Oxford Finance, to extend the availability of the final two tranches of the facility....
Feb 06, 2017 08:00 am ET
Nuvectra to Present at the Leerink Partners 6th Annual Global Healthcare Conference
PLANO, Texas, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to conduct a fireside chat presentation at the Leerink Partners 6th Annual Global Healthcare Conference in New York, NY. Management will also be available for one-on-one meetings at the conference....
Nov 21, 2016 08:00 am ET
Nuvectra to Present at the 28th Annual Piper Jaffray Healthcare Conference
PLANO, Texas, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Financial Officer, are scheduled to present at the 28th Annual Piper Jaffray Healthcare Conference in New York, NY. Management will also be available for one-on-one meetings at the conference....
Aug 10, 2016 04:01 pm ET
Nuvectra Reports Second Quarter 2016 Financial Results
PLANO, Texas, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended July 1, 2016....
Aug 08, 2016 08:00 am ET
Nuvectra Announces Formation of Medical Advisory Board
PLANO, Texas, Aug. 08, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the formation of the Nuvectra Medical Advisory Board (“MAB”). The Nuvectra MAB is composed of three renowned experts in neurostimulation therapies and pain medicine. The MAB will serve as a key strategic resource for the Company as it commercializes the Algovita® Spinal Cord Stimulation System. The MAB will help guide the development of clinical study and marketing strategies, clinician education programs, and future pipeline initiatives....
Jul 27, 2016 04:01 pm ET
Nuvectra to Report Second Quarter 2016 Financial Results on August 10, 2016
PLANO, Texas, July 27, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended July 1, 2016 on Wednesday, August 10, 2016 after the market close....
Jun 28, 2016 09:00 am ET
Nuvectra Added to the Russell Microcap® Index
PLANO, Texas, June 28, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has been added to the Russell Microcap® Index. The addition occurred at the close of trading on June 24, 2016 when FTSE Russell reconstituted its comprehensive set of U.S. and global indexes....
May 11, 2016 04:01 pm ET
Nuvectra Reports First Quarter 2016 Financial Results
PLANO, Texas, May 11, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended April 1, 2016....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.